IL246734B - Identification of functional cell states - Google Patents

Identification of functional cell states

Info

Publication number
IL246734B
IL246734B IL246734A IL24673416A IL246734B IL 246734 B IL246734 B IL 246734B IL 246734 A IL246734 A IL 246734A IL 24673416 A IL24673416 A IL 24673416A IL 246734 B IL246734 B IL 246734B
Authority
IL
Israel
Prior art keywords
identification
functional cell
cell states
states
functional
Prior art date
Application number
IL246734A
Other languages
English (en)
Hebrew (he)
Other versions
IL246734A0 (en
Original Assignee
Asedasciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asedasciences Ag filed Critical Asedasciences Ag
Publication of IL246734A0 publication Critical patent/IL246734A0/en
Publication of IL246734B publication Critical patent/IL246734B/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00Subject matter not provided for in other groups of this subclass
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30Prediction of properties of chemical compounds, compositions or mixtures
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40Searching chemical structures or physicochemical data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
IL246734A 2014-01-14 2016-07-12 Identification of functional cell states IL246734B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927247P 2014-01-14 2014-01-14
PCT/US2015/011441 WO2015109003A1 (en) 2014-01-14 2015-01-14 Identification of functional cell states

Publications (2)

Publication Number Publication Date
IL246734A0 IL246734A0 (en) 2016-08-31
IL246734B true IL246734B (en) 2019-06-30

Family

ID=52440877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL246734A IL246734B (en) 2014-01-14 2016-07-12 Identification of functional cell states

Country Status (11)

Country Link
US (3) US11137388B2 (enExample)
EP (1) EP3094974B1 (enExample)
JP (1) JP6606100B2 (enExample)
KR (1) KR102413041B1 (enExample)
AU (2) AU2015206520B2 (enExample)
CA (1) CA2972960C (enExample)
DK (1) DK3094974T3 (enExample)
ES (1) ES2728119T3 (enExample)
IL (1) IL246734B (enExample)
SG (1) SG11201705495XA (enExample)
WO (1) WO2015109003A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states
CA2977481C (en) 2015-02-24 2021-02-02 The University Of Tokyo Dynamic high-speed high-sensitivity imaging device and imaging method
EP3372985B1 (en) 2015-10-28 2025-06-25 The University Of Tokyo Analysis device
US10824693B2 (en) 2015-12-10 2020-11-03 Reservoir Labs, Inc. Systems and methods for selective expansive recursive tensor analysis
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US12300357B2 (en) 2016-12-14 2025-05-13 FlowJo, LLC Applied computer technology for management, synthesis, visualization, and exploration of parameters in large multi-parameter data sets
US11573182B2 (en) 2017-05-25 2023-02-07 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
WO2019241443A1 (en) 2018-06-13 2019-12-19 Thinkcyte Inc. Methods and systems for cytometry
US11972858B2 (en) 2019-05-14 2024-04-30 University Of Pittsburgh-Of The Commonwealth System Of Higher Education System and method for characterizing cellular phenotypic diversity from multi-parameter cellular, and sub-cellular imaging data
EP4083603A4 (en) 2019-12-27 2024-04-03 ThinkCyte, Inc. FLOW CYTOMETER PERFORMANCE EVALUATION METHODS AND STANDARD PARTICLE SUSPENSION
WO2021200960A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 観察装置
WO2021200911A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 フローサイトメーター
WO2022026532A1 (en) * 2020-07-30 2022-02-03 Allen Institute Systems, devices, and methods for compound screening using predictive tagging
US20240337647A1 (en) 2021-07-26 2024-10-10 Asedasciences Ag Improved methods for identification of functional cell states
WO2023056481A1 (en) * 2021-10-01 2023-04-06 CAP Diagnostics, LLC, dba Pathnostics Automated methods and systems for rapid identification of target particles
US12105081B2 (en) * 2021-10-20 2024-10-01 Travera, Inc. Treatment response assessment using normalized single cell measurements
IL322273A (en) 2023-01-23 2025-09-01 Asedasciences Ag Improved human-computer interaction systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544650A (en) * 1988-04-08 1996-08-13 Neuromedical Systems, Inc. Automated specimen classification system and method
AU6024294A (en) 1993-01-08 1994-08-15 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US7166424B2 (en) 1998-02-02 2007-01-23 Odyssey Thera Inc. Fragments of fluorescent proteins for protein fragment complementation assays
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6998249B1 (en) 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
WO2001067103A1 (en) 2000-03-06 2001-09-13 Bioseek, Inc. Function homology screening
EP1290428A1 (en) 2000-06-02 2003-03-12 Medicometrics APS Method and system for classifying a biological sample
US7146349B2 (en) * 2000-11-06 2006-12-05 International Business Machines Corporation Network for describing multimedia information
WO2004094609A2 (en) 2003-04-23 2004-11-04 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles
WO2008134593A1 (en) * 2007-04-25 2008-11-06 President And Fellows Of Harvard College Molecular circuits
WO2009146036A2 (en) * 2008-04-01 2009-12-03 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences
US20130226469A1 (en) 2008-04-01 2013-08-29 Purdue Research Foundation Gate-free flow cytometry data analysis
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states

Also Published As

Publication number Publication date
US11137388B2 (en) 2021-10-05
DK3094974T3 (da) 2019-05-27
JP6606100B2 (ja) 2019-11-13
AU2021204419A1 (en) 2021-07-22
US11867690B2 (en) 2024-01-09
JP2017505140A (ja) 2017-02-16
US20160370350A1 (en) 2016-12-22
KR102413041B1 (ko) 2022-06-23
ES2728119T3 (es) 2019-10-22
KR20160110444A (ko) 2016-09-21
CA2972960A1 (en) 2015-07-23
US20210364499A1 (en) 2021-11-25
AU2015206520B2 (en) 2021-07-22
SG11201705495XA (en) 2017-08-30
EP3094974B1 (en) 2019-02-27
EP3094974A1 (en) 2016-11-23
AU2015206520A1 (en) 2016-07-14
IL246734A0 (en) 2016-08-31
WO2015109003A1 (en) 2015-07-23
HK1231553A1 (en) 2017-12-22
US20150198584A1 (en) 2015-07-16
CA2972960C (en) 2022-01-11

Similar Documents

Publication Publication Date Title
IL274903A (en) cell
IL246734A0 (en) Identification of functional cell states
IL250511A0 (en) Crystalline forms of ibrutinib
SG11201609265RA (en) Characterizing states of subject
GB201419865D0 (en) Solution
IL239830B (en) Case
GB201407805D0 (en) Battery condition determination
AU359704S (en) Case
HUE049608T2 (hu) Elektrolitoldat
SG11201610831PA (en) Lithium-sulphur battery
SG11201610430QA (en) Growth-independent detection of cells
GB2531512B (en) Context-sensitive identification of regions of interest
GB201411985D0 (en) Battery
GB201419650D0 (en) Modified heterocyclase
PL3149792T3 (pl) Ogniwo litowo-siarkowe
GB2531332B (en) Location identification
GB2559497B (en) Functional wall-tie
GB201604427D0 (en) Modified cell
GB201414968D0 (en) Cell assay
GB201403494D0 (en) Identifying cell features
GB201413459D0 (en) Identification of objects
GB201413650D0 (en) Wallets
GB201410934D0 (en) T cell
GB201419149D0 (en) Wallet
GB201417979D0 (en) Abstract accelerationon

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed